Bryostatin is a drug derived from a type of symbiont bacteria. Although bryostatin has been used in clinical trials for oncology, results have not been excellent.
This patent teaches that bryostatin and various derivatives thereof are useful for stimulation of hematopoietic stem cell proliferation.
It will be interesting to see if bryostatin works on stimulating stem cell activity of other stem cell sources such as tissue stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.